| PRISM Stock Indexes | Current Value | % Change (Daily) | % Change (Inception) | Most Active | Top % Gainers | Top % Losers |
|---|---|---|---|---|---|---|
| Cannabis | $49.00 | -5.5% | -51.0% | SNDL 100,953 | % | CGC -8.285% |
| EV | $63.90 | -4.8% | -36.1% | NKLA 13,243 | SPAQ 5.556% | FSR -12.795% |
| Gene Therapy | $48.80 | -3.1% | -51.2% | DRNA 3,032 | ORGS 11.905% | SGMO -11.471% |
| MedDevices | $178.20 | -3.5% | 78.2% | ATRS 4,882 | CRY 1.418% | CUTR -19.379% |
| MedDiagnostics | $100.10 | -2.9% | 0.1% | OPK 4,323 | THMO 6.423% | OSUR -19.031% |
| Solar | $79.50 | -2.7% | -20.5% | HYSR 7,166 | CSIQ 5.079% | MAXN -8.978% |
| Uranium | $87.40 | -3.3% | -12.6% | UEC 16,561 | NXE 0.873% | BKUCF -8.75% |
| Vaccines & Cell Therapy | $188.80 | -4.5% | 88.8% | SRNE 9,563 | DYAI 10.329% | SIGA -15.512% |
| Web 3.0 | $44.00 | -6% | -56.0% | MARA 11,296 | SNII 3.33% | HIVE -10.118% |
HONG KONG (Reuters) – China and the United States are committed to reach an arrangement on the audit inspection issue that is in line with…
[Read More]
The modern investor needs trusted, relevant information, delivered quickly and concisely. CEO3in60 provides a platform for management to succinctly share their company’s value proposition in their own words. We take the CEOs of the most dynamic up and coming companies and put them in front of the camera to provide you with the top three reasons why you should be paying attention to their business, all in less than sixty seconds.
Asensus Surgical (NYSE American: ASXC) is leading the digital surgical market with Performance-Guided Surgery™, which enhances the work of surgeons using state-of-the-art robotics, augmented intelligence and machine learning. Shameze Rampertab, Chief Financial Officer at Asensus, outlines three value drivers for investors that will have the market paying attention in the coming months.
Soligenix (NASDAQ: SNGX) is developing and commercializing products to treat rare diseases in oncology and dermatology where there is an unmet medical need. Chris Schaber, President and CEO of Soligenix, Inc. spends one minute outlining three value drivers that will have investors
Read more about Soligenix, Inc.
